There’s no doubt that small-cap companies can offer some eye-watering returns to early investors, but in the small-cap space the risks are elevated as companies often have a limited track record and investors are reliant on the accuracy of management teams’ forecasts. Get it right and you can ride huge winners like Pro Medicus Ltd (ASX: PME) or Corporate Travel Management Ltd (ASX: CTD) to 1,000% plus returns in periods of around 5 years. However, get it wrong and you can lose nearly all your money as shown by the likes of iSentia Group Ltd (ASX: ISD), Admedus Ltd (ASX:…
You can continue reading this story now by entering your email below
There’s no doubt that small-cap companies can offer some eye-watering returns to early investors, but in the small-cap space the risks are elevated as companies often have a limited track record and investors are reliant on the accuracy of management teams’ forecasts.
Another little-known small-cap share that’s nearly quadrupled from $2.24 to $8.73 over just the past 5 years is Citadel Group Ltd (ASX: CGL).
Citadel is a provider of software-as-a-service solutions to public and private sector enterprises that grew basic earnings per share and net profit 35% and 26% over FY 2018.
Its management team also boasted of having a “record sales pipeline” over FY 2019, while being “well placed” to grow earnings in “FY19 and beyond”.
As a provider of software and cloud services Citadel is operating in a fashionable area for growth-oriented investors and has a market value around $428 million based on a share price of $8.73. In other words its small size means it could double or triple again if the business’s growth plans work out well.
However, it’s vulnerable to competition that could see performance deteriorate, while it also trades on around 22x FY 2018’s profits. In other words its valuation leaves little room for error if it cannot deliver more revenue and profit growth over FY 2019.
With interest rates likely to stay at rock bottom for months (or YEARS) to come, income-minded investors have nowhere to turn... except dividend shares. That’s why The Motley Fool’s top analysts have just prepared a brand-new report, laying out their top 3 dividend bets for 2019.
Hint: These are 3 shares you’ve probably never come across before.
They’re not the banks. Not Woolies or Wesfarmers or any of the “usual suspects.”
We think these 3 shares offer solid growth prospects over the next 12 months. The first two currently offer fat, fully franked yields. The last is a surprising REIT offering you the benefits of being a landlord with none of the hassle! You’ll discover all three names and codes in "The Motley Fool’s Top 3 Dividend Shares for 2019."
Even better, your copy is free when you click the link below. Fair warning: This report is brand new and may not be available forever. Click the link below to be among the first investors to get access to this timely, important new research!
The names of these top 3 dividend bets are all included. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.
Motely Fool writer Tom Richardson owns shares in Pro Medicus and Corporate Travel. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Corporate Travel Management Limited and Pro Medicus Ltd. The Motley Fool Australia has recommended iSentia Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.